Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1159.75 -24.90 (-2.10%) | NSE 1159.60 -27.10 (-2.28%) | Trade | Add

BSE Live

Feb 18, 16:01

1159.75 -24.90 (-2.10%)

Volume

AVERAGE VOLUME

5-Day

67,207

10-Day

80,845

30-Day

74,124

95,224

Prev. Close

1184.65
Open Price

1186.45

Bid Price (Qty.)
1164.00 (3)
Offer Price (Qty.)
1171.10 (229)

NSE Live

Feb 18, 15:59

1159.60 -27.10 (-2.28%)

Volume

AVERAGE VOLUME

5-Day

2,138,896

10-Day

2,647,181

30-Day

1,750,557

3,294,006

Prev. Close

1186.70
Open Price

1188.60

Bid Price (Qty.)
1159.60 (1510)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
Per Share Ratios
Basic EPS (Rs.)	94.36	23.91	54.09	42.95	13.03
Diluted EPS (Rs.)	94.36	23.91	54.09	42.95	13.03
Cash EPS (Rs.)	111.49	39.24	67.97	56.42	22.62
Book Value [ExclRevalReserve]/Share (Rs.)	343.57	245.69	227.05	174.22	170.00
Book Value [InclRevalReserve]/Share (Rs.)	343.57	245.69	227.05	174.22	170.00
Dividend / Share(Rs.)	5.00	4.50	3.25	2.50	1.50
Revenue from Operations/Share (Rs.)	583.64	519.88	415.67	351.72	261.67
PBDIT/Share (Rs.)	154.17	57.79	86.79	69.01	36.86
PBIT/Share (Rs.)	137.04	42.46	72.91	55.54	27.26
PBT/Share (Rs.)	127.29	29.03	63.10	42.35	16.70
Net Profit/Share (Rs.)	94.36	23.91	54.09	42.95	13.03
Profitability Ratios
PBDIT Margin (%)	26.41	11.11	20.87	19.61	14.08
PBIT Margin (%)	23.47	8.16	17.54	15.79	10.41
PBT Margin (%)	21.80	5.58	15.18	12.03	6.38
Net Profit Margin (%)	16.16	4.59	13.01	12.21	4.97
Return on Networth / Equity (%)	27.46	9.73	23.82	24.65	7.66
Return on Capital Employed (%)	26.64	8.94	15.95	12.51	8.75
Return on Assets (%)	11.38	3.16	8.26	6.86	2.77
Total Debt/Equity (X)	1.02	1.60	1.44	2.13	1.33
Asset Turnover Ratio (%)	0.75	0.74	0.65	0.64	0.63
Liquidity Ratios
Current Ratio (X)	1.53	1.73	2.13	2.28	1.71
Quick Ratio (X)	0.99	1.24	1.51	1.72	1.25
Inventory Turnover Ratio (X)	2.53	2.68	2.63	2.90	2.93
Dividend Payout Ratio (NP) (%)	5.27	18.82	6.04	5.82	11.70
Dividend Payout Ratio (CP) (%)	4.46	11.47	4.80	4.43	6.73
Earnings Retention Ratio (%)	94.73	81.18	93.96	94.18	88.30
Cash Earnings Retention Ratio (%)	95.54	88.53	95.20	95.57	93.27
Valuation Ratios
Enterprise Value (Cr.)	7,282.65	3,048.64	3,082.63	5,098.86	4,699.48
EV/Net Operating Revenue (X)	2.24	1.09	1.38	2.72	3.37
EV/EBITDA (X)	8.48	9.81	6.61	13.85	23.94
MarketCap/Net Operating Revenue (X)	1.64	0.37	0.70	1.93	2.61
Retention Ratios (%)	94.72	81.17	93.95	94.17	88.29
Price/BV (X)	2.79	0.77	1.28	3.90	4.02
Price/Net Operating Revenue	1.64	0.37	0.70	1.93	2.61
Earnings Yield	0.10	0.13	0.19	0.06	0.02